|
This session will examine key policies in the areas of early detection screening, access to treatments, clinical trials participation, and other areas that have a direct impact on the prostate cancer racial disparity.
Moderator: J. Jacques Carter, MD, MPH, Assistant Professor, Harvard Medical School
Welcome: Mr. Thomas A. Farrington, PHEN President and Founder
Remarks: U.S. Congressman Gregory Meeks, 5th District of New York
Celebrating 20 Years Presentation Part I: Ms. Tomeeka Miller, PHEN Director of Communications
Why Early Detection Screening Policies and Guidelines Are Priority: Keith Crawford, MD, PhD, PHEN Director of Clinical Trials and Patient Education
Panel Discussion on Prostate Cancer Policy Initiatives and Needs: Moderator: Mr. Anthony “Tony” Hill, PHEN Policy Coordinator
Closing Remarks: Dr. J. Jacques Carter
| 
